First Amendment to License Agreement, dated March 29, 2005, between The Trustees of Columbia University in the City of New York and Omnimmune Corp

Contract Categories: Intellectual Property - License Agreements
EX-10.9 28 ex10-9.htm ex10-9.htm
Exhibit 10.9
 
COLUMBIA UNIVERSITY SCIENCE AND TECHNOLOGY VENTURES
 
FIRST AMENDMENT TO THE LICENSE AGREEMENT OF
 
FEBRUARY 1, 2005 BETWEEN COLUMBIA AND OMNIMMUNE CORP.
 
March 29, 2005
 
Harris A. Lichtenstein, Ph.D.
President and CEO
Omnimmune Corp.
4600 Post Oak Place
Suite 152
Houston, Texas 77027

Dear Harris:

The Agreement between Omnimmune Corp. and The Trustees of Columbia University in the City of New York, dated February 1, 2005 (“Agreement”), is hereby amended as follows:

1.     
Section 17 (a) is amended to read as follows:

a.  This Agreement shall be effective as of the date first recited above and shall continue in full force and effect until its expiration or termination in accordance with this Section 17; provided however that if the Stock Purchase Agreement or the Stockholders Agreement involving Columbia and Omnimmune is not fully executed within 120 days of the effective date of this Agreement, then this Agreement is null and void.

All other terms and conditions of the Agreement shall remain in full force and effect, except as expressly amended herein.

Please indicate your agreement to the Letter Amendment by signing where indicated below, and returning one original signed Letter to my attention.

Very truly yours,

/s/ Scot G. Hamilton                             
Scot G. Hamilton
Senior Director
Science and Technology Ventures
The Trustees of Columbia University in the City of New York
 
AGREED AND ACKNOWLEDGED:

OMNIMMUNE CORP.

By:/s/ Harris A. Lichtenstein                                                                               
President & CEO

Date:3/29/05